PMID- 25190137
OWN - NLM
STAT- MEDLINE
DCOM- 20141215
LR  - 20181202
IS  - 1744-7666 (Electronic)
IS  - 1465-6566 (Linking)
VI  - 15
IP  - 16
DP  - 2014 Nov
TI  - Pharmacotherapy for treatment of retinal vein occlusion.
PG  - 2373-84
LID - 10.1517/14656566.2014.956083 [doi]
AB  - INTRODUCTION: Retinal vein occlusion (RVO) is a common vascular condition, which 
      may cause blindness and impaired vision as a result of the development of macular 
      oedema. The management of macular oedema due to RVO is complex and a 
      multidisciplinary approach is required in order to limit disease progression and 
      achieve a better clinical outcome. AREAS COVERED: An update and a brief review on 
      the current treatment strategies were provided in patients with macular oedema 
      following RVOs. Evidence available from prospective, multicentre clinical studies 
      evaluating the use of VEGF inhibitors and steroids and from a selective 
      literature search is reported. EXPERT OPINION: For many years, laser 
      photocoagulation has been considered the standard of care for the treatment of 
      branch RVO. However, new treatment modalities have been evaluated through 
      randomised controlled trials. Recently, anti-VEGF agents and corticosteroids have 
      been shown to be efficacious options in the treatment of RVO.
FAU - Sarao, Valentina
AU  - Sarao V
AD  - University of Udine, Department of Ophthalmology , Piazza Santa Maria della 
      Misericordia, 33100 Udine , Italy +39 0432559907 ; +39 0432559904 ; 
      paolo.lanzetta@uniud.it.
FAU - Bertoli, Federica
AU  - Bertoli F
FAU - Veritti, Daniele
AU  - Veritti D
FAU - Lanzetta, Paolo
AU  - Lanzetta P
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20140905
PL  - England
TA  - Expert Opin Pharmacother
JT  - Expert opinion on pharmacotherapy
JID - 100897346
RN  - 0 (Glucocorticoids)
RN  - 0 (Vascular Endothelial Growth Factor A)
SB  - IM
CIN - Expert Opin Pharmacother. 2015 Feb;16(3):447-8. PMID: 25496360
CIN - Expert Opin Pharmacother. 2015 Feb;16(3):448. PMID: 25741543
MH  - Glucocorticoids/therapeutic use
MH  - Humans
MH  - Macular Edema/*drug therapy/etiology
MH  - Randomized Controlled Trials as Topic
MH  - Retinal Vein Occlusion/complications/*drug therapy
MH  - Vascular Endothelial Growth Factor A/antagonists & inhibitors
OTO - NOTNLM
OT  - VEGF.
OT  - dexamethasone
OT  - laser
OT  - retinal vein occlusion
OT  - steroids
OT  - triamcinolone
EDAT- 2014/09/06 06:00
MHDA- 2014/12/17 06:00
CRDT- 2014/09/06 06:00
PHST- 2014/09/06 06:00 [entrez]
PHST- 2014/09/06 06:00 [pubmed]
PHST- 2014/12/17 06:00 [medline]
AID - 10.1517/14656566.2014.956083 [doi]
PST - ppublish
SO  - Expert Opin Pharmacother. 2014 Nov;15(16):2373-84. doi: 
      10.1517/14656566.2014.956083. Epub 2014 Sep 5.